Chemotherapy in pancreatic cancer: Results of a controlled, prospective, randomised, multicentre trial

British Medical Journal

Volumn 281, Issue 6255, 1980, Pages 1589-1591

  Mallinson, C N ^a   Rake, M O ^b   Cocking, J B ^c   Fox, C A ^a   Cwynarski, M T ^b   Diffey, B L ^b   Jackson, G A ^b   Hanley, J ^a   Wass, V J ^b  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^b KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^c Isle of Thanet District Hospital ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; MITOMYCIN; VINCRISTINE;

ADVERSE DRUG REACTION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; HAIR LOSS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; PANCREAS; PANCREAS CANCER; PANCREAS CARCINOMA; RANDOMIZED CONTROLLED TRIAL; THERAPY; THROMBOCYTOPENIA;

ADULT; AGED; CLINICAL TRIALS; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MITOMYCINS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; VINCRISTINE;

EID: 0019208060     PISSN: 00071447     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.281.6255.1589     Document Type: Article

References (15)

1. Carter S.K., Comis R.L. The integration of chemotheraphy into a combined modality approach for cancer treatment. V. 1. Pancreatic adenocarcinoma. Cancer Treat Rev 1975;2:193-214.
2. Mallinson C.N., Rake M.O., Fox C.A., Cwynarski M.T., Cocking J.B., Jackson G.A., Diffey B.L. Gut 1976;17:826-827.
3. Karnofsky D.A. Meaningful clinical classification of therapeutic responses to anti-cancer drugs. Clin Pharm Ther 1961;2:709-712.
4. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.
5. Moertel C.G., Douglass H.O., Hanley J., Carbone P.P. Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide. Cancer 1977;40:605-608.
6. Schein P.S., Lavin P.T., Moertel C.G., et al. Randomised Phase II clinical trial of adriamycin, methotrexate and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumour Study Group Report. Cancer 1978;42:19-22.
7. Moertel C.G., Lokish J.J., Childs D.S. Jr, Lavin P.T. An evaluation of high dose radiation and combined radiation and 5-fluorouracil therapy for locally unresectable pancreatic carcinoma. Proceedings of the American Association of Cancer Research and American Society of Clinical Oncology 1976;17:244.
8. Abderhalden R.T., Bukowski R.M., Groppe C.W., Hewlett J.S., Weick J.K. Streptozotocin, 5-fluorouracil with and without mitomycin-C in the treatment of pancreatic adenocarcinoma. Proceedings of the American Association of Cancer Research and American Society of Clinical Oncology 1977;18:301.
9. Wiggans R.G., Woolley P.V., Macdonald J.S., Smythe T., Winston P.A., Ueno W., Schein P.S. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil in the treatment of advanced pancreatic cancer. Cancer 1978;41:387-391.
10. Smith F.P., Macdonald J.S., Woolley P.V., et al. Phase II evaluation of FAM 5-fluorouracil (F), adriamycin (A), and mitomycin-C (M) in advanced pancreatic cancer. Proceedings of the American Association of Cancer Research and American Society of Clinical Oncology 1979; 20:415.
11. Bitran J.D., Dresser R.K., Kozloff M.F., Billings A.A., Shapiro C.M. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil adriamycin and mitomycin-C. Cancer Treatment Reports 1979; 63: 2049–51.
12. Krauss S., Sonoda T., Solomon A. Treatment of advanced gastro-intestinal cancer with 5-fluorouracil and mitomycin-C. Cancer 1979;43:1598-1603.
13. Buroker T., and 15 other authors. 5-FU infusion with mitomycin-C vs 5-FU infusion with methyl CCNU in the treatment of advanced upper gastro-intestinal cancer. A South-West Oncology Group Study. Cancer 1979;44:1215-1221.
14. Davis H.L., Von Hoff D.D., Rozencweig M., Handelsman H., Soper W.T., Muggia F.M. In: Staquet M.J., ed, Randomised trials in cancer: a critical review by sites. New York: Raven Press, 1978:147-230.
15. Hanham I.W.F., Newton K.A., Westbury G. Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regimen. Br J Cancer 1971; 25:462-78.